ITRM vs MAR · rev $390.0K vs P/E 32, rev $26.19B
Iterum Therapeutics PLC (ITRM) versus Marriott International Inc (MAR) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Marriott International Inc (MAR) is a lodging company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
ITRM currently screens at market cap $38.6M. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Not investment advice. Open the ITRM and MAR stock pages for the full models.
Not investment advice.